Written by : Dr. Aishwarya Sarthe
October 4, 2024
The decision was made during the 26th session of the IMDRF in September 2024, held in Seattle, Washington, USA.
In a move to bolster its medical device regulatory framework and enhance international collaboration, the Central Drugs Standard Control Organisation (CDSCO) has been approved as an Affiliate Member of the International Medical Device Regulators Forum (IMDRF).
The decision was made during the 26th session of the IMDRF in September 2024, held in Seattle, Washington, USA.
This membership is expected to improve regulatory alignment for India's medical device industry on a global scale.
CDSCO, under India’s Ministry of Health and Family Welfare, applied for IMDRF Affiliate Membership to align India's medical device regulations with global standards. The membership was approved after detailed discussions between the IMDRF Management Committee and senior officers of the CDSCO.
Established in 2011, the IMDRF is a voluntary group of medical device regulators from various countries, including the United States, Australia, Japan, and the European Union, aimed at harmonizing international medical device regulations.
IMDRF membership includes regulatory authorities from key regions like South Korea, Singapore, Brazil, Russia, China, and others. By becoming an affiliate, India will participate in global efforts to simplify regulatory complexities and ensure public health protection through collaboration and convergence of regulations.
The newly acquired affiliate status is crucial for India as it provides opportunities for collaboration with regulators worldwide. It also supports the creation of a regulatory framework that meets international standards, improving the competitiveness of India’s medical device industry.
The IMDRF membership will also help in the use of IMDRF documents as references or part of India's medical device regulatory guidelines.
This membership enables India to participate in IMDRF Open Sessions, where technical discussions occur among international regulators. This exchange of information will help India adapt its strategies and frameworks to evolving trends in medical device regulation. India's membership also provides a platform to share its perspectives on medical device regulation while learning from other member countries' experiences.
An official from CDSCO noted, "The affiliate membership in IMDRF offers a platform to share knowledge and enhance our regulatory framework by learning from global best practices. This step is significant for India's medical device industry to align with international standards."
By being part of this forum, CDSCO will also gain insights into advanced regulatory techniques, emerging trends, and innovative technologies, which will play a pivotal role in shaping the future of India's medical device sector.
The membership aims to streamline the regulatory approval processes for medical devices, ensuring timely access to new and innovative healthcare technologies for Indian citizens.
India’s medical device manufacturers will also benefit significantly from this membership. With harmonized regulatory requirements, Indian devices will find it easier to meet global standards, facilitating smoother access to international markets.
"This membership will enable Indian manufacturers to meet the regulatory demands of IMDRF member countries, further enhancing the 'Brand India' image in global healthcare markets," a CDSCO spokesperson remarked.
The membership aligns with India's vision to make its medical device sector more globally competitive and recognized.
For manufacturers, the benefits include reduced regulatory barriers and enhanced opportunities for international trade. The IMDRF membership also assures international partners of India's commitment to maintaining high standards in medical device manufacturing and regulation.